Adam Laponis insider trades

Open-market stock purchases and sales by Adam Laponis, Chief Financial Officer at Twist Bioscience Corp, from SEC Form 4 filings since Oct 20, 2020.

Recent trades

DateStockTradeValue
May 29, 2026TWST Twist Bioscience CorpSold$280K
May 21, 2026TWST Twist Bioscience CorpSold$108K
Apr 17, 2026TWST Twist Bioscience CorpSold$240K
Apr 14, 2026TWST Twist Bioscience CorpSold$165K
Apr 9, 2026TWST Twist Bioscience CorpSold$130K
Feb 23, 2026TWST Twist Bioscience CorpSold$97.4K
Feb 12, 2026TWST Twist Bioscience CorpSold$350K
Jan 13, 2026TWST Twist Bioscience CorpSold$120K
Jan 9, 2026TWST Twist Bioscience CorpSold$96.5K
Nov 21, 2025TWST Twist Bioscience CorpSold$23.5K
Nov 18, 2025TWST Twist Bioscience CorpBought (not open market)—
Oct 30, 2025TWST Twist Bioscience CorpSold$173K
Oct 28, 2025TWST Twist Bioscience CorpBought (not open market)—
Oct 9, 2025TWST Twist Bioscience CorpSold$82.9K
Oct 8, 2025TWST Twist Bioscience CorpSold$93.5K
Oct 6, 2025TWST Twist Bioscience CorpSold$189K

Companies traded

  • TWST Twist Bioscience Corp: 25 sales, last May 29, 2026
  • EAR Eargo, Inc: 5 sales, last Nov 20, 2023

Get free alerts when Adam Laponis files a new trade →